HLA ligandomics identifies histone deacetylase 1 as target for ovarian cancer immunotherapy

The recent approval of clincially effective immune checkpoint inhibitors illustrates the potential of cancer immunotherapy. A challenging task remains the identification of specific targets guiding immunotherapy. Facilitated by technical advances, the direct identification of physiologically relevan...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Peper, Janet Kerstin, Bösmüller, Hans-Christian, Schuster, Heiko, Gückel, Brigitte, Hörzer, Helen, Roehle, Kevin, Schäfer, Richard, Wagner, Philipp, Rammensee, Hans-Georg, Stevanović, Stefan, Fend, Falko, Staebler, Annette
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2015
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4910750/
https://ncbi.nlm.nih.gov/pubmed/27467910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1065369
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados